Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morinidazole versus metronidazole for infected acute biliary pancreatitis
ChiCTR1900020552Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Wenzhou Medical University
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of morinidazole in biliary pancreatitis (2 arms), sponsored by The First Affiliated Hospital of Wenzhou Medical University. Primary endpoint: Clinical cure rate. Planned start Jan 2019; status: not yet recruiting.
02
Drugs
morinidazole
03
Conditions
biliary pancreatitis
Beyond the preview
Go deeper on ChiCTR1900020552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900020552.